Previous 10 | Next 10 |
SEATTLE, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ: ATOS ), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today anno...
SEATTLE, July 30, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announces inter...
Will These Penny Stocks Stay Below $4.50? Are penny stocks part of your trading strategy right now? With so many options available like crypto, options, futures, and, of course, blue-chip socks , it can be something to consider. However, not all penny stocks are “good for your heal...
SEATTLE, July 27, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company with a current focus on breast cancer and COVID-19, announces that Atossa’s CEO, Dr. Steven Quay, M.D., Ph.D., will present at Tribe Public’s Zoom We...
Mexco Energy (NYSEMKT: MXC ) +153% . More news on: Mexco Energy Corporation, Oblong Inc., Oragenics, Inc., Stocks on the move, , Read more ...
Atossa Therapeutics ( ATOS ) has contracted with Australia based Avance Clinical Pty Ltd to conduct a clinical trial of its proprietary drug candidate AT-301, to be administered by nasal spray. More news on: Atossa Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read ...
SEATTLE, July 16, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that ...
Atossa Therapeutics ( ATOS +23.8% ) announces positive results from in vitro testing of AT-301, its proprietary COVID-19 nasal spray drug candidate. More news on: Atossa Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SEATTLE, July 15, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announced...
SEATTLE, July 08, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced it ha...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...